Close

ACOR Financial Facts

Interest income: 46K
Provision for income taxes: -3.02M
See Full Income Statement

Other assets: 5.81M
Accounts payable: 18.56M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date N/A EPS Growth Rate -139.7% *Last Qtr.
Average EPS % Beat Rate -188.2% Revenue Growth Rate +63.1% *Last Qtr.
Average % Move 1-Wk after EPS -8.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/8/23 Q223 -$7.55N/A N/A $29.68MN/A N/A Details
8/4/22 Q222 -$3.15-$0.36 -$2.79$18.2M$29.1M N/A Details
3/4/21 Q420 -$2.50-$1.48 -$1.02$38.16M$34M N/A Details
5/11/23 Q123 -$0.69N/A N/A $22.25MN/A N/A Details
2/15/18 Q417 $0.61$1.05 -$0.44$188.4M$174.75M = Details
5/2/18 Q118 $0.14$0.47 -$0.33$106.2M$129.87M = Details
11/4/11 Q311 $0.40$0.73 -$0.33$93.03M$90.78M N/A Details
10/31/17 Q317 $0.43$0.65 -$0.22$141.07M$150.64M = Details